Debt-to-equity of SUPERNUS PHARMACEUTICALS, INC. from 30 Sep 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
SUPERNUS PHARMACEUTICALS, INC. quarterly Debt-to-equity in % history and change rate from 30 Sep 2012 to 30 Sep 2025.
  • SUPERNUS PHARMACEUTICALS, INC. Debt-to-equity for the quarter ending 30 Sep 2025 was 32%, a 14% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

SUPERNUS PHARMACEUTICALS, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 32% -5% -14% 30 Sep 2025
Q2 2025 31% -8% -20% 30 Jun 2025
Q1 2025 33% -7% -17% 31 Mar 2025
Q4 2024 36% -18% -34% 31 Dec 2024
Q3 2024 37% -30% -44% 30 Sep 2024
Q2 2024 39% -42% -52% 30 Jun 2024
Q1 2024 40% -57% -59% 31 Mar 2024
Q4 2023 54% -43% -45% 31 Dec 2023
Q3 2023 67% -34% -34% 30 Sep 2023
Q2 2023 81% -18% -18% 30 Jun 2023
Q1 2023 97% -2% -2.2% 31 Mar 2023
Q4 2022 97% -2% -2.3% 31 Dec 2022
Q3 2022 101% +3% +2.9% 30 Sep 2022
Q2 2022 100% -4% -3.9% 30 Jun 2022
Q1 2022 99% -10% -9.1% 31 Mar 2022
Q4 2021 100% -9% -8% 31 Dec 2021
Q3 2021 98% -9% -8.2% 30 Sep 2021
Q2 2021 104% 0% +0.12% 30 Jun 2021
Q1 2021 109% +12% +12% 31 Mar 2021
Q4 2020 108% +6% +6.2% 31 Dec 2020
Q3 2020 107% 0% -0.2% 30 Sep 2020
Q2 2020 103% -9% -8% 30 Jun 2020
Q1 2020 98% -19% -16% 31 Mar 2020
Q4 2019 102% -19% -16% 31 Dec 2019
Q3 2019 107% -4% -3.6% 30 Sep 2019
Q2 2019 112% +15% +16% 30 Jun 2019
Q1 2019 116% +36% +45% 31 Mar 2019
Q4 2018 121% +66% +121% 31 Dec 2018
Q3 2018 111% +56% +102% 30 Sep 2018
Q2 2018 97% +39% +68% 30 Jun 2018
Q1 2018 80% +13% +20% 31 Mar 2018
Q4 2017 55% -21% -28% 31 Dec 2017
Q3 2017 55% -34% -38% 30 Sep 2017
Q2 2017 58% -48% -45% 30 Jun 2017
Q1 2017 67% -43% -39% 31 Mar 2017
Q4 2016 76% -39% -34% 31 Dec 2016
Q3 2016 89% -45% -34% 30 Sep 2016
Q2 2016 105% -56% -35% 30 Jun 2016
Q1 2016 110% -76% -41% 31 Mar 2016
Q4 2015 115% -112% -49% 31 Dec 2015
Q3 2015 134% -91% -40% 30 Sep 2015
Q2 2015 162% -132% -45% 30 Jun 2015
Q1 2015 185% -134% -42% 31 Mar 2015
Q4 2014 226% -36% -14% 31 Dec 2014
Q3 2014 225% +34% +18% 30 Sep 2014
Q2 2014 294% +160% +120% 30 Jun 2014
Q1 2014 319% +221% +225% 31 Mar 2014
Q4 2013 262% +126% +93% 31 Dec 2013
Q3 2013 191% -46% -19% 30 Sep 2013
Q2 2013 133% 30 Jun 2013
Q1 2013 98% 31 Mar 2013
Q4 2012 136% 31 Dec 2012
Q3 2012 237% 30 Sep 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.